Financials
Financial year 2025
CW Life Sciences Consulting from Antwerpen, company number BE1011510951, closed financial year 2025 with a result of € 133,647 after tax. For that financial year CW Life Sciences Consulting recorded a gross margin of € 181,358 and equity of € 187,735. Compared with financial year 2024, the result moved from € 49,088 to € 133,647. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 187,735
▲ 247% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 133,647
▲ 172% vs 2024
Profit after tax over the fiscal year.
€ 238,952
▲ € 205,140 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 182,735.
People and assets in 2025
€ 570
▲ € 483 vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 762
▼ 52% vs 2024
Loans from banks and other lenders, long and short.
€ 8,379
Supplier invoices still open on the last day of the fiscal year.
€ 77,901
▲ 246% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 62,014 | € 181,358 | ▲ 192% |
| Profit after taxes | € 49,088 | € 133,647 | ▲ 172% |
| Equity | € 54,088 | € 187,735 | ▲ 247% |
| Total debts | € 32,617 | € 88,024 | ▲ 170% |
| Cash | € 33,812 | € 238,952 | ▲ € 205,140 |
| Retained profit | € 49,088 | € 182,735 | ▲ 272% |
| Bank debt | € 1,580 | € 762 | ▼ 52% |
| Balance sheet total | € 86,705 | € 275,759 | ▲ 218% |
Key figures of CW Life Sciences Consulting, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to CW Life Sciences Consulting?
What happened at CW Life Sciences Consulting in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 133,647 (▲ 172% vs 2024). Source: NBB ↗
- New establishment in Antwerpen. KBO
- Kurt Ceuppens became a director. NBB
- Dieter Willekens became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 49,088 profit in 2024 to € 133,647 profit in 2025.
Paid € 52,670 in corporate taxes since 2024.
Best year ever: 2025, with € 133,647 profit.
A new publication or filing at CW Life Sciences Consulting? We notify you, reason included.
Follow CW Life Sciences ConsultingDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind CW Life Sciences Consulting are Kurt Ceuppens and Dieter Willekens. Kurt Ceuppens is also behind E&C Consultancy.
Directors
According to the 2025 annual accounts
since 2024
Dieter Willekens
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Elisabethlaan 1 box 103
2600 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →Sagret
€ -3,302 gross margin · 2025
GOUDEN LINK
€ -9,386 gross margin · 2023
ADVOCAAT KARIN VANDERZANDE
€ 51,386 gross margin · 2024
Genealogical Research
Advocatenkantoor De Raedemaecker
€ 31,261 gross margin · 2025
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1011.510.951
- VAT number
- BE 1011.510.951
- Registered office
- Elisabethlaan 1 bus 103, 2600 Antwerpen
- Names & denominations
- CW Life Sciences Consulting
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 July 2024
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van vertalers
Uitgeven van overige software
Overige zakelijke dienstverlening, neg
Vertalers en tolken